Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1.
about
Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cellsCytokine inhibition in the treatment of COPD.Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycinIncreased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.Endothelial MMP14 is required for endothelial-dependent growth support of human airway basal cells.Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.Oxidative stress and the development of endothelial dysfunction in congenital heart disease with increased pulmonary blood flow: lessons from the neonatal lamb.COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy.An FGFR1-SPRY2 Signaling Axis Limits Basal Cell Proliferation in the Steady-State Airway Epithelium.Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease.Therapeutic perspectives in bronchial vascular remodeling in COPD.Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerThe role of the bronchial microvasculature in the airway remodelling in asthma and COPD.Angiogenesis and vascular remodeling in chronic airway diseases.Therapeutic and pathological roles of fibroblast growth factors in pulmonary diseases.Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.Immunocytochemical colocalization of fibroblast growth factor-1 with neurotrophin-3 in mouse alveolar macrophages.Activation of heat shock response augments fibroblast growth factor-1 expression in wounded lung epithelium.Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile.Azithromycin attenuates fibroblast growth factors induced vascular endothelial growth factor via p38(MAPK) signaling in human airway smooth muscle cells.Prioritizing chronic obstructive pulmonary disease (COPD) candidate genes in COPD-related networks.Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.[Relationship between FGFR1 Gene Regulation of Circulating Tumor Cells and Clinical Features of Non-small Cell Lung Cancer].
P2860
Q24658237-7FACDB28-517D-4F4D-B6FC-4616E7A37FB3Q33568552-0B92ADC1-C95D-4151-956F-3048F68264D1Q35207699-7145699B-008A-452C-872B-0D6A4F840DE2Q35830712-D67D8996-F5AB-4C5B-9830-CA156B7A1659Q35969103-12ECACA4-4C2A-48A6-85C9-4D11876E12B2Q36120008-E0AA3DF9-152E-4C65-B9F1-A45EDBC2348FQ36480016-B57E6C89-66F0-4277-A477-516CADD08A76Q36546997-7526EC90-769C-4F76-AF8B-CDF4222F366AQ36779299-66FA3A9C-563C-4A65-B65C-7CC791659CFEQ36780120-9D171B82-EB17-4C0F-A51B-432A821B1146Q37082574-9337A83F-5B0C-431C-825F-C18C0B643E7DQ37362620-81988C15-5824-4BBE-AAF6-3153509760E4Q37413167-307AA101-1641-4BEE-BA2D-2F4A2A630471Q37797577-89A7BFC9-3163-4A9C-A14A-D1B1DDDC30B1Q38131445-580F914E-7DE8-43C0-AF70-4A802B8366D4Q38991364-776F185E-A9F7-4468-8F0F-AFC2F2F52A6EQ39804008-CC29C873-B5C6-4D74-87E9-DC351A37B824Q42002471-57D45CB3-9172-4793-B8F1-39D55A00F1ACQ42784197-56C2BCD4-AAF7-49FE-BBD9-5BD63557F429Q42909637-88DE7792-7643-4DF6-AA0B-44CC1C7070F5Q44927752-574A3B8B-9ECA-4615-8811-FD609A879377Q45401517-B2D090D7-D6DC-4BCD-B6CF-3381F2686360Q47113578-86E1FA8C-E0BF-453F-82F3-AF21FC3CB365Q48156403-A69EBD6D-9F4A-4375-BDDB-7A4FC0ADF6D5Q55440995-44028F69-340D-4D1C-95C2-04D7A1E635E2
P2860
Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@en
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@nl
type
label
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@en
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@nl
prefLabel
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@en
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@nl
P2093
P2860
P356
P1476
Chronic obstructive pulmonary ...... n of FGF-1, FGF-2, and FGFR-1.
@en
P2093
Andor R Kranenburg
Anna Willems-Widyastuti
Hari S Sharma
Peter J Sterk
Pramod R Saxena
Willem I de Boer
Wolter J Mooi
P2860
P356
10.1002/PATH.1748
P577
2005-05-01T00:00:00Z